scPharmaceuticals Inc. — Director's Dealing 2021

Jun 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: scPharmaceuticals Inc. (SCPH)
CIK: 0001604950
Period of Report: 2021-06-08

Reporting Person: VEITINGER KLAUS R DR (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-08	Stock Option (Right to Buy)	$5.70	A	16300	Acquired	2031-06-08	Common Stock (16300)	Direct

Footnotes

F1: This stock option vests in full upon the earlier of (i) June 8, 2022, and (ii) the next annual meeting of the Issuer's stockholders.